Home
Features
-
CDMOs: Biomanufacturing Expansion Updates
Expansions in biomanufacturing (biologic drug substances) continues to be an active area of investment by CDMOs/CMOs. Which companies are expanding? DCAT Value Chain Insights rounds up the latest developments.
-
Tariffs, Strategies & Biotech: Where Do Things Stand?
Biotech industry groups, Biotechnology Innovation Organization (US) and EuropaBio (Europe), weigh in on evolving US trade policy and how to strengthen the life-sciences industry’s competitiveness.
-
SPONSORED CONTENT
NaOH Solution: Benefits of Vertical Integration in the Pharma Supply Chain
-
SPONSORED CONTENT
Latest Investments in High Containment Confirm Indena’s Excellence in CDMO Services
-
SPONSORED CONTENT
Overcoming Barriers To Patient Adherence With A Novel Dosage Form
DCAT MEMBER COMPANY COMMUNITY
-
New Podcast Episode! Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies)? Is there too much capacity or is the market tight? The latest episode of…
-
ESG Update: DCAT Member Companies in the Community
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…
-
New Member Company Alert
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. To View all DCAT member companies visit the Member Directory. From…
-
New! ESG Update: DCAT Member Companies in the Community
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…
